Enhancing miR-132 expression by aryl hydrocarbon receptor attenuates tumorigenesis associated with chronic colitis.

MLA

Alzahrani, Abdullah M., et al. “Enhancing MiR-132 Expression by Aryl Hydrocarbon Receptor Attenuates Tumorigenesis Associated with Chronic Colitis.” International Immunopharmacology, vol. 52, Nov. 2017, pp. 342–51. EBSCOhost, https://doi.org/10.1016/j.intimp.2017.09.015.

APA

Alzahrani, A. M., Hanieh, H., Ibrahim, H. M., Mohafez, O., Shehata, T., Bani Ismail, M., & Alfwuaires, M. (2017). Enhancing miR-132 expression by aryl hydrocarbon receptor attenuates tumorigenesis associated with chronic colitis. International Immunopharmacology, 52, 342–351. https://doi.org/10.1016/j.intimp.2017.09.015

Chicago

Alzahrani, Abdullah M., Hamza Hanieh, Hairul-islam Mohamed Ibrahim, Omar Mohafez, Tamer Shehata, Mohammad Bani Ismail, and Manal Alfwuaires. 2017. “Enhancing MiR-132 Expression by Aryl Hydrocarbon Receptor Attenuates Tumorigenesis Associated with Chronic Colitis.” International Immunopharmacology 52 (November): 342–51. doi:10.1016/j.intimp.2017.09.015.